Aliya Khan is a Clinical Professor of Medicine in the Division of Endocrinology and Geriatrics at McMaster University, Director of the Calcium Disorders Clinic, and Director of the Fellowship in Metabolic Bone Disease at McMaster University. She graduated from the University of Ottawa Medical School with honors. She trained in Internal Medicine, Geriatric Medicine and Endocrinology and also completed a fellowship in Metabolic Bone Disease at the University of Toronto. She has published over 200 scientific papers and numerous chapters and books on osteoporosis and parathyroid disease.

Dr. Khan led the development of global guidelines for parathyroid disease, osteonecrosis of the jaw, new diagnostic criteria for hypophosphatasia , as well as treatment guidelines for X-linked hypophosphatemia in addition to Canadian guidelines for osteoporosis.

She is the principle investigator evaluating novel therapies for parathyroid disease including PTH and PTH analogues as well PTH1receptor agonists for the treatment of hypoparathyroidism including palopegteriparatide, natpar, eneboparatide as well as the calcilytic molecule encalaret for the treatment of autosomal dominant hypocalcemia. In addition she was the principle investigator evaluating bisphosphonate therapy as well as the calcimetic cinacalcet for the medical management of primary hyperparathyroidism.

She has received numerous national and international awards including the Queen’s Diamond Jubilee Medal for excellence, International Hypoparathyroidism Award, International Osteoporosis Foundation award for publishing excellence and recognized by Osteoporosis Canada for outstanding contributions to research and education. In 2024 she was the recipient of the Woman Physician of the Year Award by the American College of Physicians (ACP) Ontario Chapter honoring an outstanding woman physician with a distinguished career in areas of exceptional patient care, medical education and/or research. She also received the ACP Humanitarian of the Year Award given for outstanding contributions to humanism in medicine and also recognizes scholarly activities in literature, philosophy, and ethics. She is recognized as being in the top 0.1% of the world experts in hyperparathyroidism by Expertscape

Aliya Khan is a Clinical Professor of Medicine in the Division of Endocrinology and Geriatrics at McMaster University, Director of the Calcium Disorders Clinic, and Director of the Fellowship in Metabolic Bone Disease at McMaster University. She graduated from the University of Ottawa Medical School with honors. She trained in Internal Medicine, Geriatric Medicine and Endocrinology and also completed a fellowship in Metabolic Bone Disease at the University of Toronto. She has published over 200 scientific papers and numerous chapters and books on osteoporosis and parathyroid disease.

Dr. Khan led the development of global guidelines for parathyroid disease, osteonecrosis of the jaw, new diagnostic criteria for hypophosphatasia , as well as treatment guidelines for X-linked hypophosphatemia in addition to Canadian guidelines for osteoporosis.

She is the principle investigator evaluating novel therapies for parathyroid disease including PTH and PTH analogues as well PTH1receptor agonists for the treatment of hypoparathyroidism including palopegteriparatide, natpar, eneboparatide as well as the calcilytic molecule encalaret for the treatment of autosomal dominant hypocalcemia. In addition she was the principle investigator evaluating bisphosphonate therapy as well as the calcimetic cinacalcet for the medical management of primary hyperparathyroidism.

She has received numerous national and international awards including the Queen’s Diamond Jubilee Medal for excellence, International Hypoparathyroidism Award, International Osteoporosis Foundation award for publishing excellence and recognized by Osteoporosis Canada for outstanding contributions to research and education. In 2024 she was the recipient of the Woman Physician of the Year Award by the American College of Physicians (ACP) Ontario Chapter honoring an outstanding woman physician with a distinguished career in areas of exceptional patient care, medical education and/or research. She also received the ACP Humanitarian of the Year Award given for outstanding contributions to humanism in medicine and also recognizes scholarly activities in literature, philosophy, and ethics. She is recognized as being in the top 0.1% of the world experts in hyperparathyroidism by Expertscape

Research Interests: Genetic and Molecular Epidemiology

Research Interests: Genetic and Molecular Epidemiology

Dr. Steinberg obtained his PhD in 2002 from the University of Guelph.   His research thesis was conducted in the laboratory of Professor David Dyck where he studied the regulation of metabolism in muscle by the hormone leptin.  From 2002-2006, Dr. Steinberg conducted Postdoctoral Research in the laboratory of  Professor Bruce Kemp at St. Vincent’s Institute of Medical Research in Melbourne, Australia.  During this time he gained insight into protein biochemistry and molecular biology with an emphasis on the metabolic stress sensing protein kinase AMPK.  In 2006, Dr. Steinberg became Head of the Metabolism Unit at St. Vincent’s Institute of Medical Research and a Senior Fellow of the National Health and Medical Research Council of Australia.   In 2009, Dr. Steinberg returned to Canada and joined the Department of Medicine, Endocrinology and Metabolism Division as an Associate Professor and Canada Research Chair.  His laboratory is currently funded by grants from CFI, CIHR, CDA and NSERC.

Dr. Steinberg obtained his PhD in 2002 from the University of Guelph.   His research thesis was conducted in the laboratory of Professor David Dyck where he studied the regulation of metabolism in muscle by the hormone leptin.  From 2002-2006, Dr. Steinberg conducted Postdoctoral Research in the laboratory of  Professor Bruce Kemp at St. Vincent’s Institute of Medical Research in Melbourne, Australia.  During this time he gained insight into protein biochemistry and molecular biology with an emphasis on the metabolic stress sensing protein kinase AMPK.  In 2006, Dr. Steinberg became Head of the Metabolism Unit at St. Vincent’s Institute of Medical Research and a Senior Fellow of the National Health and Medical Research Council of Australia.   In 2009, Dr. Steinberg returned to Canada and joined the Department of Medicine, Endocrinology and Metabolism Division as an Associate Professor and Canada Research Chair.  His laboratory is currently funded by grants from CFI, CIHR, CDA and NSERC.